Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Advances in Therapy|March 12, 2016
Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III TrialsFrancesco Locatelli, Gabriel Choukroun, Matt Truman, et al.
Toxins|September 22, 2022
Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic ReviewMaxime Pluquet, Said Kamel, Gabriel Choukroun, et al.
Case Reports in Critical Care|November 12, 2016
Plasma Exchange in the Management of Catastrophic Antiphospholipid SyndromeDimitri Titeca-Beauport, Valery Salle, Loay Kontar, et al.
Fundamental & Clinical Pharmacology|January 17, 2022
Risk factors for and characteristics of community- and hospital-acquired drug-induced acute kidney injuriesAmayelle Rey, Valérie Gras-Champel, Gabriel Choukroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Exploring dosing frequency and administration routes in the treatment of anaemia in CKD patientsJose Portolés, Peter Krisper, Gabriel Choukroun, et al.
BMJ Open|March 12, 2013
Anaemia management with C.E.R.A. in routine clinical practice: OCEANE (Cohorte Mircera patients non-dialyses), a national, multicenter, longitudinal, observational prospective study, in patients with chronic kidney disease not on dialysisLuc Frimat, Christophe Mariat, Paul Landais, et al.
Frontiers in Pharmacology|July 22, 2022
Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French DatabasesAmayelle Rey, Valérie Gras, Julien Moragny, et al.
Plos One|July 7, 2020
Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registryOriane Lambert, Cécile Couchoud, Marie Metzger, et al.
Journal of Clinical Medicine|January 25, 2025
Efficacy and Safety of Roxadustat in Patients with CKD: Pooled Analysis by Baseline Inflammation StatusGabriel Choukroun, Frank Strutz, Alexander Harkavyi, et al.
Journal of Nephrology|October 7, 2021
Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injuryAmayelle Rey, Valérie Gras-Champel, Thibaut Balcaen, et al.
Pageof 18